What Clinicians Should Know About the QT Interval

2003667 citationsReview

Authors

Sana M. Al‐Khatib · Duke Energy (United States)

Nancy M. Allen LaPointe · Clinical Research Institute

Judith M. Kramer · Clinical Research Institute

Robert M. Califf · Clinical Research Institute

Abstract

Although the use of QT-prolonging medications can predispose to torsades de pointes, there is a relative paucity of information that can help clinicians and patients make optimal informed decisions about how best to minimize the risk of this serious complication.

Topics & Keywords

Cardiac electrophysiology and arrhythmias ECG Monitoring and Analysis Cardiac pacing and defibrillation studies

UN Sustainable Development Goals

Quality Education

Publication Details

Published in: JAMA

Volume 289, Issue 16, pp. 2120-7

DOI: 10.1001/jama.289.16.2120

Field-Weighted Citation Impact: 21.01